Preview

Вестник травматологии и ортопедии имени Н.Н. Приорова

Расширенный поиск

Преимущества и недостатки различных методов лечения болезни Дюпюитрена

https://doi.org/10.32414/0869-8678-2017-2-61-68

Полный текст:

Аннотация

Представлены данные об используемых в настоящее время методах лечения болезни Дюпюитрена - консервативных, радикальных хирургических, малоинвазивных, показаны их преимущества и недостатки. К сожалению, ни один из методов не позволяет избежать рецидивов заболевания на разных сроках после лечения. В отсутствие единого подхода к выбору тактики лечения все большую популярность завоевывают малоинвазивные методики, такие как игольчатая апоневротомия, инъекционное введение коллагеназы, чрескожная апоневротомия с использование липофилинга (липографтинга) и др.

Об авторах

А. А. Улищенко
ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России
Россия


И. О. Голубев
ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России
Россия


Список литературы

1. Lanting R., Broekstra D.C., Werker P.M. et al. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of western countries. Plast. Reconstr. Surg. 2014; 133 (3): 593-603. doi: 10.1097/01.prs.0000438455.37604.0f.

2. Микусев И.Е. Причины и профилактика повторных операций при контрактуре Дюпюитрена. Казанский медицинский журнал. 1995; LXXVI (5): 385-7.

3. Сиваконь С.В. Комплексное хирургическое лечение контрактуры Дюпюитрена. Автореф. дис.. д-ра мед. наук. М.; 2004.

4. Тарик Я.М. Оперативное лечение тяжелых форм контрактуры Дюпюитрена. Автореф. дис. … канд. мед. наук. М.: 2005.

5. Беюл А.П. Оперативное лечение дюпюитреновской контрактуры. В кн.: Сборник работ хирургических клиник І ММИ. М.; 1938: 82-96.

6. Воробьев В.Н. Контрактура Дюпюитрена и ее хирургическое лечение. Вестник хирургии. 1957; 12: 41-6.

7. Брянцева Л.Н. Контрактура Дюпюитрена. Л.: Медицина; 1963.

8. Meyerding H.A., Black J.R., Broders A.C. The etiology and pathology of Dupuytren’s contracture. Surg. Gynecol. Obs tet. 1941; 72: 582-90.

9. James J., Tubiana R. Dupuytren’s disease. Rev. Chir. Orthop. Reparatrice Appar. Mot. 1952; 38 (3-4): 352-406.

10. McCash C.R. The open palm technique in Dupuytren’s contracture. Br. J. Plast. Surg. 1964; 17: 271-80.

11. Burge P., Hoy G., Regan P., Milne R. Smoking, alcohol and the risk of Dupuytren’s contracture. J. Bone Joint Surg. Br. 1997; 79 (2): 206-10.

12. Noble J., Arafa M., Royle S.G. et al. The association between alcohol, hepatic pathology and Dupuytren’s disease. J. Hand Surg. Br. 1992; 17 (1): 71-4.

13. Smith S.P., Devaraj V.S., Bunker T.D. The association between frozen shoulder and Dupuytren’s disease. J. Shoulder Elbow Surg. 2001; 10 (2): 149-51.

14. Bonnici A.V., Birjandi F., Spencer J.D. et al. Chromosomal abnormalities in Dupuytren’s contracture and carpal tunnel syndrome. J. Hand Surg. Br. 1992; 17 (3): 349-55.

15. Mikkelsen O.A. Dupuytren’s diseaseinitial symptoms, age of onset and spontaneous course. Hand. 1977; 9 (1): 11-5.

16. Langemak G.E. Zur Thiosinaminbehandlung der Dupuytren’schen Faschienkontraktur. M_nchener Med Wochenschr. 1907; 54: 1380.

17. Dominguez-Malagon H.R., Alfeiran-Ruiz A., Chavarria- Xicotencatl P. Duran-Hernandez M.S. Clinical and cellular effects of colchicine in fibromatosis. Cancer. 1992; 69 (10): 2478-83.

18. Murrell G.A.C., Francis M.J.O., Bromley L. The collagen changes of Dupuytren’s contracture. J. Hand Surg. Br. 1991; 16: 263-6.

19. Ketchum L.D., Donahue T.K. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J. Hand Surg. Am. 2000; 25: 1157-62. doi: 10.1053/ jhsu.2000.18493.

20. Rayan G.M. Dupuytren’s disease: anatomy, pathology, presentation, and treatment. J. Bone Joint Surg. Am. 2007; 89 (1): 189-98.

21. Evans R.B., Dell P.C., Fiolkowski P. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren’s contracture. J. Hand Ther. 2002; 15 (4): 331-9.

22. Larson D., Jerosch-Herold C. Clinical effectiveness of postoperative splinting after surgicalrelease of Dupuytren’s contracture: a systematic review. BMC Musculoskelet. Disord. 2008; 9: 104. doi: 10.1186/1471- 2474-9-104.

23. Jerosch-Herold C., Shepstone L., Chojnowski A.J., Larson D. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s Contracture a pragmatic, multicentre, randomized controlled trial. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 323-32. doi.org/10.1007/978-3-642-22697-7_41.

24. Rigotti G., Marchi A., Galie_ M. et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose derived adult stem cells. Plast. Reconstr. Surg. 2007; 119 (5): 1409-22. doi: 10.1097/01.prs.0000256047.47909.71.

25. Keilholz L., Seegenschmiedt M.H., Born A.D., Sauer R. Radiotherapy in the early stages of Dupuytren’s disease: indication, technique, long-term results. Strahlenther Onkol. 1997; 173: 27-35.

26. Betz N., Ott O.J., Adamietz B. et al. Radiotherapy in early-stage Dupuytren’s contracture. Long-term results after 13 years. Strahlenther Onkol. 2010; 186 (2): 82-90. doi: 10.1007/s00066-010-2063-z.

27. Seegenschmiedt M.H., Keilholz L., Wielpьtz M. et al. Long-term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 349-371. doi.org/10.1007/978-3-642-22697-7_44.

28. Ball C., Izadi D., Verjee L.S., Chan J. Systematic review of non-surgical treatments for early dupuytren’s disease. BMC Musculoskelet. Disord. 2016; 17 (1): 345. doi: 10.1186/s12891-016-1200-y.

29. Badalamente M.A., Hurst L.C. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J. Hand Surg. Am. 2007; 32: 767-74. doi: 10.1016/j.jhsa.2007.04.002.

30. Smeraglia F., Del Buono A., Maffulli N. Collagenase clostridium histolyticum in Dupuytren’s contracture: a systematic review. Br. Med. Bull. 2016; 118 (1): 149-58. 1-10. doi: 10.1093/bmb/ldw020.

31. Hurst L.C., Badalamente M.A. et al. CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N. Engl. J. Med. 2009; 361 (10): 968-79. doi: 10.1056/NEJMoa0810866.

32. Coleman S., Gilpin D., Kaplan F.T. et al. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J. Hand Surg. Am. 2014; 39 (1): 57-64. doi: 10.1016/j. jhsa.2013.10.002.

33. Mickelson D.T., Noland S.S., Watt A.J. et al. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for Dupuytren contracture. J. Hand Surg. Am. 2014; 39 (10): 1933-41.e1. doi: 10.1016/j.jhsa.2014.07.010.

34. Ашкенази А.И. Хирургия кистевого сустава. Серия: Библиотека практического врача. М.: Медицина; 1990.

35. Волкова A.M. Хирургия кисти. т. 2. Свердловск. 1993: 10-58.

36. Van Rijssen A.L., Ter Linden H., Werker P.M.N. 3-year results of first-ever randomised clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 281-8. doi: 10.1007/978-3-642-22697-7_35.

37. Chick L.R., Lister G.D. Surgical alternatives in Dupuytren’s contracture. Hand Clin. 1991; 7 (4): 715-9.

38. Clibbon J.J. Logan A.M. Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal flexion contracture. J. Hand Surg. Br. 2001; 26 (4): 360-1. doi: 10.1054/jhsb.2001.0602.

39. Misra A., Jain A. Ghazanfar R. et al. Predicting the out- come of surgery for the proximal interphalangeal joint in Dupuytren’s disease. J. Hand Surg. 2007; 32 (2): 240-5. doi: 10.1016/j.jhsa.2006.11.015.

40. Denkler K. Surgical complications associated with fasciectomy for Dupuytren’s disease: a 20 year review of the english literature. Eplasty. 2010; 10: e15.

41. Pess G.M., Pess R.M., Pess R.A. Results of needle aponeurotomy for Dupuytren сontracture in over 1,000 fingers. J. Hand Surg. Am. 2012; 37 (4): 651-6. doi: 10.1016/j. jhsa.2012.01.029.

42. Foucher G., Cornil C.H., Lenoble E. ‘Open palm’ technique in Dupuytren’s disease. Postoperative complications and results after more than 5 years. Chirurgie. 1992; 118 (4): 18-94 [Article in French].

43. Ketchum L. Expanded Dermofasciectomies and full- thickness grafts in the treatment of Dupuytren’s contracture: a 36-year experience. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 213-20. doi.org/10.1007/978-3-642-22697-7_26

44. Armstrong J.R., Hurren J.S., Logan A.M. Dermofasciectomy in the management of Dupuytren’s disease. J. Bone Joint Surg. Br. 2000; 82 (1): 90-4.

45. Harrison S.H., Morris A. Dupuytren’s Contracture: the dorsal transposition flap. Hand. 1975; 7 (2): 145-9.

46. Laurenza F., Gensini A. Rotation of a skin flap from the side of the finger to the volar surface in the treatment of Dupuytren’s disease. Ital. J. Orthop. Traumatol. 1992; 18 (1): 37-41.

47. Ozdemir O., Co_ckunol E., I_cik B. The surgical treatment of Dupuytren contracture with the reverse flow dorsal metacarpal island flap. Tech. Hand Up Extrem. Surg. 2000; 4 (2): 137-40.

48. Lukas B., Lukas M. Flap plasty in advanced Dupuytren’s disease. Oper. Orthop. Traumatol. 2016; 28 (1): 20-9. doi: 10.1007/s00064-015-0435-3.

49. Жигало А.В. Особенности хирургической тактики при лечении больных с тяжелыми формами контрактуры Дюпюитрена. Автореф. дис. … канд. мед. наук. СПб; 2010.

50. Badois F.J., Lermusiaux J.L., Masse C., Kuntz D. Non- surgical treatment of Dupuytren disease using needle fasciotomy. Rev. Rhum. Ed Fr. 1993; 60 (11): 808-13 [Article in French].

51. Van Rijssen A.L., Gerbrandy F.S., Ter Linden H. et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J. Hand Surg. Am. 2006; 31 (5): 717-25. doi: 10.1016/j.jhsa.2006.02.021.

52. Van Rijssen A.L., Werker P.M. Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg. Br. 2006; 31 (5): 498-50.

53. Chen N.C., Srinivasan R.C., Shauver M.J., Chung K.C. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand (NY). 2011; 6 (3): 250-5. doi 10.1007/ s11552-011-9326-8

54. Hovius S.E., Kan H.J., Smit X. et al. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast. Reconstr. Surg. 2011; 128 (1): 221-8.

55. Coleman S.R. Structural fat grafting: More than a permanent filler. Plast. Reconstr. Surg. 2006; 118 (3 Suppl): 108S-20S. doi: 10.1097/01.prs.0000234610.81672.e7.

56. Rigotti G., Marchi A., Galie_ M. et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose derived adult stem cells. Plast. Reconstr. Surg. 2007; 119 (5): 1409-22. doi: 10.1097/01.prs.0000256047.47909.71.

57. Khouri R.K., Smit J.M., Cardoso E. et al. Percutaneous aponeurotomy and lipofilling: A regenerative alternative to flap reconstruction? Plast. Reconstr. Surg. 2013; 132 (5): 1280-90. doi: 10.1097/PRS.0b013e3182a4c3a9.

58. Kan H.J., Selles R.W., van Nieuwenhoven C.A. et al. Percutaneous aponeurotomy and lipofilling (PALF) versus limited fasciectomy in patients with primary Dupuytren’s contracture: prospective, randomized, controlled trial. Plast. Reconstr. Surg. 2016; 137 (6): 1800-12. doi: 10.1097/PRS.0000000000002224.

59. Lipman M.D., Carstensen S.E., Deal D.N. Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014. Hand (N Y). 2017; 12 (1): 13-20. doi: 10.1177/1558944716647101.

60. Магомедов Р.О., Микусев Г.И., Байкеев Р.Ф. и др. Регистр болезни (контрактуры) Дюпюитрена по Республике Татарстан: эффективность хирургического лечения. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2013; 1: 10-7.


Для цитирования:


Улищенко А.А., Голубев И.О. Преимущества и недостатки различных методов лечения болезни Дюпюитрена. Вестник травматологии и ортопедии имени Н.Н. Приорова. 2017;(2):61-68. https://doi.org/10.32414/0869-8678-2017-2-61-68

For citation:


Ulishchenko A.A., Golubev I.O. Advantages and Disadvantages of Various methods for Dupuytren’s Contracture. N.N. Priorov Journal of Traumatology and Orthopedics. 2017;(2):61-68. (In Russ.) https://doi.org/10.32414/0869-8678-2017-2-61-68



Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0869-8678 (Print)
ISSN 2658-6738 (Online)